nitroxoline has been researched along with 6h-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide, 4-(4-chlorophenyl)-n-(4-hydroxyphenyl)-2,3,9-trimethyl-, (6s)- in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, K; Hu, T; Jiang, H; Jiang, X; Luo, C; Luo, X; Qiao, G; Shen, J; Wang, J; Wang, X; Xing, J; Yang, F; Zhang, R; Zheng, M | 1 |
1 other study(ies) available for nitroxoline and 6h-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide, 4-(4-chlorophenyl)-n-(4-hydroxyphenyl)-2,3,9-trimethyl-, (6s)-
| Article | Year |
|---|---|
Rational design of 5-((1H-imidazol-1-yl)methyl)quinolin-8-ol derivatives as novel bromodomain-containing protein 4 inhibitors.
Topics: Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Computer-Aided Design; Drug Design; Humans; Imidazoles; Leukemia; Multiple Myeloma; Nitroquinolines; Nuclear Proteins; Proto-Oncogene Proteins c-myc; Quinolines; Structure-Activity Relationship; Transcription Factors; Triple Negative Breast Neoplasms | 2019 |